Date: 30 July 2018
Times: To be agreed with attendees
Venue: DMS Whittington. Lichfield, WS14 9PY
Following on from the CORTISONE Industry Day on 17 May at Tech UK in London, the programme wishes to invite potential suppliers to demonstrate their products to relevant MoD clinical military professionals.
These Discovery Days are intended to inform MoD clinicians who will be asked to provide input to the refinement of CORTISONE requirements. Note that they will not be able to enter into dialogue about the requirements as part of the Discovery Day.
Discovery Day 1 on Monday 30 July 2018 will look at Primary Healthcare systems. This is the first of two initial CORTISONE Discovery Days. Further Discovery Days, if required, will be announced later.
At present, we are only interested in product demonstrations covering all of the following:
- Core clinical functionality (e.g. patient registration, appointment management, consultation management, templates, split screen viewing different parts of the clinical record, internal messaging, prescribing, clinical coding SNOMED, and document management).
- Patient facing features (e.g. patient app, e-appointment booking, e-prescription re-ordering, SMS).
- Reporting and Mobile working capabilities.
- Integration capabilities and the additional clinical/business modules their product interfaces with, such as order communications, electronic document management systems etc.
Suppliers should assume standard NHS clinical practice and patient pathways.
Suppliers able to demonstrate potentially suitable products are invited to request a place on the day by sending an email stating the products they intend to demonstrate to: Alexander.Slowman100@mod.gov.uk no later than 10:00 on Wednesday 25 July 2018. Further information will be supplied to confirmed attendees.
Responding to this announcement is voluntary and does not start the official procurement process for the CORTISONE requirement. Participation in the Discovery Days does not guarantee, or jeopardise, your inclusion in a future procurement exercise. It should be noted that all information released in relation to the Discovery Days is released on a without commitment basis, is subject to change and may not form part of any future procurement process.
No down-selection will take place as a consequence of any responses or interactions relating to the Discovery Days. Additionally, no information provided in response to this announcement or in relation to the Discovery Days will be used in any way for the purpose of evaluating suppliers or their products in any future procurement process.
What is Programme CORTISONE?
CORTISONE is a programme looking to deliver Defence Medical Services with an integrated ecosystem of multiple medical information services. Its vision is to deliver ‘a sustainable, integrated, cohesive and enduring information capability that will fully and effectively support the delivery of evidence-based medical and dental health and healthcare outputs, to achieve the Aim of the Defence Medical Services (DMS)’ – which is to Promote, Protect and Restore the health of the Defence population in order to maximise their fitness for role, while maintaining an occupational focus and an operational edge.
A multi-million-pound programme, with global reach and operations equivalent in size to two large CCGs (Clinical Commissioning Groups) and a Community Trust, CORTISONE looks to procure a full suite of healthcare software from multiple healthcare product/service suppliers, together with develop and deliver services. It is anticipated that elements of the ecosystem will be re-competed on a regular basis to ensure the best solutions are being delivered to users, giving an ongoing opportunity for market players to get involved with the ecosystem on a long-term basis.
The MoD is looking for a range of companies to engage with the programme, delivering a full-suite of healthcare software to meet use-cases and patient-journey-defined functional requirements. With the modular nature of the procurement allowing innovation, all suppliers are encouraged to take a leading role in delivery of functionality.
CORTISONE is also looking to the future – to exploit innovations which will align with NHS strategy, virtualise healthcare and healthcare integrate services across the healthcare sector. This might include telemedicine, integration with patient records across the NHS and other patient databases, patient condition tracking, and more.